Increased NOS2 predicts poor survival in estrogen receptor-negative breast cancer patients.
about
Metabolic, autophagic, and mitophagic activities in cancer initiation and progressionThe dual role of iNOS in cancerGene expression profiles of NO- and HNO-donor treated breast cancer cells: insights into tumor response and resistance pathwaysHuman endogenous retrovirus K and cancer: Innocent bystander or tumorigenic accomplice?Macrophage-tumor cell interactions regulate the function of nitric oxideS-nitrosylation of Ras in breast cancerNitric oxide synthase and breast cancer: role of TIMP-1 in NO-mediated Akt activationNitric Oxide Down-Regulates Topoisomerase I and Induces Camptothecin Resistance in Human Breast MCF-7 Tumor CellsSignaling and stress: The redox landscape in NOS2 biologyMelanoma NOS1 expression promotes dysfunctional IFN signalingTumor microenvironment-based feed-forward regulation of NOS2 in breast cancer progression.Ets-1 is a transcriptional mediator of oncogenic nitric oxide signaling in estrogen receptor-negative breast cancer.IL-6/NOS2 inflammatory signals regulate MMP-9 and MMP-2 activity and disease outcome in nasopharyngeal carcinoma patients.Targeting RPL39 and MLF2 reduces tumor initiation and metastasis in breast cancer by inhibiting nitric oxide synthase signalingRelationship between tumor DNA methylation status and patient characteristics in African-American and European-American women with breast cancerThe Activation of the Sox2 RR2 Pluripotency Transcriptional Reporter in Human Breast Cancer Cell Lines is Dynamic and Labels Cells with Higher Tumorigenic Potential.Candidate pathways linking inducible nitric oxide synthase to a basal-like transcription pattern and tumor progression in human breast cancer.Household income is associated with the p53 mutation frequency in human breast tumorsWNT5A inhibits metastasis and alters splicing of Cd44 in breast cancer cells.Anti-metastatic and anti-tumor growth effects of Origanum majorana on highly metastatic human breast cancer cells: inhibition of NFκB signaling and reduction of nitric oxide production.Interactions among genes, tumor biology and the environment in cancer health disparities: examining the evidence on a national and global scaleInhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer.Chemotherapeutic potential of diazeniumdiolate-based aspirin prodrugs in breast cancer.Clinical Implications of iNOS Levels in Triple-Negative Breast Cancer Responding to Neoadjuvant Chemotherapy.The role of melanoma tumor-derived nitric oxide in the tumor inflammatory microenvironment: its impact on the chemokine expression profile, including suppression of CXCL10.Immunotherapeutic potential of anti-human endogenous retrovirus-K envelope protein antibodies in targeting breast tumorsNitric oxide suppresses tumor cell migration through N-Myc downstream-regulated gene-1 (NDRG1) expression: role of chelatable ironAnalysis of indoleamine 2-3 dioxygenase (IDO1) expression in breast cancer tissue by immunohistochemistryNOS Inhibition Modulates Immune Polarization and Improves Radiation-Induced Tumor Growth DelayIdentification of mammary epithelial cells subject to chronic oxidative stress in mammary epithelium of young women and teenagers living in USA: implication for breast carcinogenesis.Nitric oxide and protein phosphatase 2A provide novel therapeutic opportunities in ER-negative breast cancer.Increased sensitivity of African American triple negative breast cancer cells to nitric oxide-induced mitochondria-mediated apoptosis.Enhanced resting-state dynamics of the hemoglobin signal as a novel biomarker for detection of breast cancer.The immunogenetics of Psoriasis: A comprehensive review.S-nitrosylation of EGFR and Src activates an oncogenic signaling network in human basal-like breast cancer.Macrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pancreatic ductal adenocarcinoma.Biological signaling by small inorganic moleculesNitric Oxide Regulates Gene Expression in Cancers by Controlling Histone Posttranslational Modifications.Redox regulation of epidermal growth factor receptor signaling through cysteine oxidation.The roles of beta-adrenergic receptors in tumorigenesis and the possible use of beta-adrenergic blockers for cancer treatment: possible genetic and cell-signaling mechanisms
P2860
Q26745503-1488C07F-025C-45A6-AB7F-6C025510A88FQ26786135-F9F12BEF-F55B-43F4-B1F9-3D3D676B72A9Q26821895-AF0C3A65-1B78-494D-9016-451F0605FA14Q27010373-B60E2B33-A4E5-44FA-9307-75318536F3B9Q28384490-49087886-1BD5-41DC-8D80-C4F5A7229C94Q28387657-1C7C45D5-C0D9-481A-AB1F-DDED18D1C32AQ28483470-AE4FE8A9-1124-4B0F-B3E8-2268BD19628DQ28550726-9D8B9454-97FF-46F9-98B8-A4A95245A716Q28833738-B53910D9-4386-454A-82E0-D838FB8AA1F3Q30413226-0C60E6B0-1A5E-4AF4-A641-B0E061A2153BQ33674627-CEEB52DD-FA46-4E79-AAE3-036F35729813Q33739233-F411C208-121D-42B0-B4DC-F08ACEB35E45Q33772144-9B544120-04C0-4FFE-A895-6F0963E63F33Q33789920-49C7F39D-B737-4F8A-A52B-1A41957A9037Q34305047-8C2AD3A8-E2ED-4980-B1C1-2A833B722E64Q34452128-42F2FC99-452D-4F94-BA84-06375AA351D6Q34593813-B74D8269-90E0-41BF-895A-314C63FB46B2Q34613059-BBE77571-EAF0-413B-8F08-6BCD0C9E07CDQ34618790-BC9D16D0-241C-4FE7-89D8-C79B4F4AB0B2Q34851241-FACB415E-D39C-4DC7-859F-8EEB1930F344Q35144499-D45DD472-48DE-4536-9398-0DC817493070Q35258324-7A79CCE5-3323-4CD6-B033-EA250CD4CC5DQ35638851-747AD727-8478-4789-98DF-8D3D3C237FA4Q35701943-F9B7081E-0A34-427C-9AE2-03DA6D9AE6F2Q35718310-12C91247-5412-436D-8DE6-55AC75E377C3Q35742389-A8DCFE46-AA9D-4EF3-B941-E508B7081048Q35842150-FFBB528B-8679-4A95-A520-37B6A117C996Q35850187-41B8D6A9-6E51-4882-BDD0-0B57FEAA05B2Q35862690-D9FC38D8-BEC2-4FD7-A730-681E7E240672Q35911651-1E65C92A-103E-4666-8094-042369527F36Q36050039-EA231ACC-E673-4F95-AE2E-B765E76AA213Q36090325-7F04C9F9-B8C0-43BA-A62C-F7DDF2620132Q36171590-B1C101D0-57B7-4F6C-B400-F2034E9D38A6Q36236780-DFDAD1CB-47ED-4E76-8F1D-1A459D493289Q36294465-24A23F03-AC25-4534-A0D8-DE3DAD87A58CQ36369201-66AFAB72-92E1-4EDD-A88C-DBB5FC98E776Q36376440-83BA337F-66E9-458B-BCC2-C3871361871AQ36378173-6CF83B35-9A5F-402D-B48E-EA2B870CAEF0Q36476273-A0D9E45B-D086-4A7D-823B-5226E052F14AQ36500327-B2BE2EFB-C3C7-4A9F-8E93-C11277274AA8
P2860
Increased NOS2 predicts poor survival in estrogen receptor-negative breast cancer patients.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Increased NOS2 predicts poor s ...... gative breast cancer patients.
@ast
Increased NOS2 predicts poor s ...... gative breast cancer patients.
@en
Increased NOS2 predicts poor s ...... gative breast cancer patients.
@nl
type
label
Increased NOS2 predicts poor s ...... gative breast cancer patients.
@ast
Increased NOS2 predicts poor s ...... gative breast cancer patients.
@en
Increased NOS2 predicts poor s ...... gative breast cancer patients.
@nl
prefLabel
Increased NOS2 predicts poor s ...... gative breast cancer patients.
@ast
Increased NOS2 predicts poor s ...... gative breast cancer patients.
@en
Increased NOS2 predicts poor s ...... gative breast cancer patients.
@nl
P2093
P2860
P356
P1476
Increased NOS2 predicts poor s ...... gative breast cancer patients.
@en
P2093
Brenda J Boersma
Christopher H Switzer
Damali N Martin
David A Wink
Dong H Lee
Harris G Yfantis
Lisa A Ridnour
Robert M Stephens
Robert S Hudson
P2860
P304
P356
10.1172/JCI42059
P407
P577
2010-10-18T00:00:00Z